FREE EXPRESS SHIPPING ON ORDERS OVER $200
Retatrutide 5mg
$185.00
Retatrutide is a synthetic 39-amino acid peptide with lipidation chemistry and a sequence used in incretin-receptor research. It is classified as a multi-receptor peptide ligand containing non-standard amino acid modifications and a fatty diacid side chain. Molecular formula commonly reported for the conjugated molecule: C221H342N46O68. Molecular weight: approximately 4,731.3 g/mol.
Supplied as a lyophilised powder with >=99% purity verified by third-party HPLC analysis. A Certificate of Analysis is available for each batch. Each vial contains 5mg of Retatrutide.
Store at -20°C for long-term stability. Once reconstituted with WFI (Water for Injection), store at 4°C and use within 30 days. Protect from direct light and heat.
This product is intended for laboratory and in-vitro research purposes only and is not for human or animal consumption.
Quantity
KEY BENEFITS
- Delivers powerful appetite suppression and prolonged satiety
- Drives significant weight reduction and fat‑loss research outcomes
- Improves glycaemic control and insulin sensitivity in metabolic studies
- Enhances lipid metabolism and may support cardiovascular health
- Aids in lean‑mass preservation during caloric restriction protocols
DOSAGE AND CYCLE DURATION
Dosage
Weeks 1–4:
- Dose: 1–2 mg/week
- Notes: Starting dose, monitor side effects.
Weeks 5–8:
- Dose: 2.5–4 mg/week
- Notes: Gradual increase, assess tolerance.
Weeks 9–12:
- Dose: 5–8 mg/week
- Notes: Further escalation if needed.
Weeks 13 and beyond:
- Dose: 8–12 mg/week
- Notes: Maintenance or maximum dose, if tolerated.
Cycles
- Cycles generally span 12 to 16 weeks, with evaluation periods and potential off‑cycle breaks per protocol.
